Post-acute COVID-19 syndrome: A new pandemic?
Keywords:
post-acute COVID-19, coronavirus, complications, sequelae, recuperation.Abstract
Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has revolutionized the current public health panorama. The acute form of the disease tends to display a primarily respiratory clinical picture. However, not all patients with COVID-19 appear to fully recuperate days to weeks after the acute episode. Increasing evidence supports subacute and long-term effects of COVID-19 in several organs and systems. The term post-acute COVID-19 (COVID-pa) or prolonged COVID has been coined to refer to patients with extended recovery periods. A significant percentage of COVID-19 survivors tend to present with sequelae for up to 6 months, and considering we’re still in early stages of general recovery, these lapses could continue to grow, resulting in chronic conditions. Further research is needed to determine which patients are at risk of presenting these complications after the acute presentation in order to take appropriate preventive measures. The objective of this review is to evaluate key epidemiologic and pathophysiologic aspects of COVID-pa, aiming to facilitate its identification in clinical practice.
Downloads
References
Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. marzo de 2020;579(7798):270-3.
World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020 [Internet]. 2020 [citado 12 de mayo de 2020]. Disponible en: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020
Liu K, Chen Y, Lin R, Han K. Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients. Journal of Infection. junio de 2020;80(6):e14-8.
Geng M-J, Wang L-P, Ren X, Yu J-X, Chang Z-R, Zheng C-J, et al. Risk factors for developing severe COVID-19 in China: an analysis of disease surveillance data. Infect Dis Poverty. diciembre de 2021;10(1):48.
Alshukry A, Ali H, Ali Y, Al-Taweel T, Abu-Farha M, AbuBaker J, et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) patients in Kuwait. Tizzoni M, editor. PLoS ONE. 20 de noviembre de 2020;15(11):e0242768.
Dhar Chowdhury S, Oommen AM. Epidemiology of COVID-19. Journal of Digestive Endoscopy. marzo de 2020;11(01):03-7.
Al-Jahdhami I, Al-Naamani K, Al-Mawali A. The Post-acute COVID-19 Syndrome (Long COVID). Oman Med J. 15 de enero de 2021;36(1):e220-e220.
Greenhalgh T, Knight M, A’Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 11 de agosto de 2020;370:m3026.
Mahase E. Covid-19: What do we know about “long covid”? BMJ. 14 de julio de 2020;370:m2815.
Carfì A, Bernabei R, Landi F, for the Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 11 de agosto de 2020;324(6):603-5.
McElvaney OJ, McEvoy NL, McElvaney OF, Carroll TP, Murphy MP, Dunlea DM, et al. Characterization of the Inflammatory Response to Severe COVID-19 Illness. Am J Respir Crit Care Med. 15 de septiembre de 2020;202(6):812-21.
Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. abril de 2021;27(4):601-15.
Logue JK, Franko NM, McCulloch DJ, McDonald D, Magedson A, Wolf CR, et al. Sequelae in Adults at 6 Months After COVID-19 Infection. JAMA Netw Open. 19 de febrero de 2021;4(2):e210830.
Moreno-Pérez O, Merino E, Leon-Ramirez J-M, Andres M, Ramos JM, Arenas-Jiménez J, et al. Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. Journal of Infection. marzo de 2021;82(3):378-83.
Hincapié MA, Gallego JC, Gempeler A, Piñeros JA, Nasner D, Escobar MF. Implementation and Usefulness of Telemedicine During the COVID-19 Pandemic: A Scoping Review. J Prim Care Community Health. enero de 2020;11:215013272098061.
Garrigues E, Janvier P, Kherabi Y, Le Bot A, Hamon A, Gouze H, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. Journal of Infection. diciembre de 2020;81(6):e4-6.
Chopra V, Flanders SA, O’Malley M, Malani AN, Prescott HC. Sixty-Day Outcomes Among Patients Hospitalized With COVID-19. Ann Intern Med. abril de 2021;174(4):576-8.
Carvalho-Schneider C, Laurent E, Lemaignen A, Beaufils E, Bourbao-Tournois C, Laribi S, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clinical Microbiology and Infection. febrero de 2021;27(2):258-63.
Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. The Lancet. enero de 2021;397(10270):220-32.
Bell ML, Catalfamo CJ, Farland LV, Ernst KC, Jacobs ET, Klimentidis YC, et al. Post-acute sequelae of COVID-19 in a non-hospitalized cohort: results from the Arizona CoVHORT [Internet]. Public and Global Health; 2021 mar [citado 27 de abril de 2021]. Disponible en: http://medrxiv.org/lookup/doi/10.1101/2021.03.29.21254588
Hirschtick JL, Titus AR, Slocum E, Power LE, Hirschtick RE, Elliott MR, et al. Population-based estimates of post-acute sequelae of SARS-CoV-2 infection (PASC) prevalence and characteristics: A cross-sectional study [Internet]. Epidemiology; 2021 mar [citado 27 de abril de 2021]. Disponible en: http://medrxiv.org/lookup/doi/10.1101/2021.03.08.21252905
Ayoubkhani D, Khunti K, Nafilyan V, Maddox T, Humberstone B, Diamond I, et al. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ. 31 de marzo de 2021;372:n693.
Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. The Lancet Psychiatry. mayo de 2021;8(5):416-27.
Ou M, Zhu J, Ji P, Li H, Zhong Z, Li B, et al. Risk factors of severe cases with COVID-19: a meta-analysis. Epidemiol Infect. 2020;148:e175.
Parasher A. COVID-19: Current understanding of its pathophysiology, clinical presentation and treatment. Postgrad Med J. 25 de septiembre de 2020;0:1-9.
Inoue S, Hatakeyama J, Kondo Y, Hifumi T, Sakuramoto H, Kawasaki T, et al. Post‐intensive care syndrome: its pathophysiology, prevention, and future directions. Acute Med Surg. julio de 2019;6(3):233-46.
Carsana L, Sonzogni A, Nasr A, Rossi RS, Pellegrinelli A, Zerbi P, et al. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study. The Lancet Infectious Diseases. octubre de 2020;20(10):1135-40.
Schaller T, Hirschbühl K, Burkhardt K, Braun G, Trepel M, Märkl B, et al. Postmortem Examination of Patients With COVID-19. JAMA. 23 de junio de 2020;323(24):2518-20.
Ghazavi A, Ganji A, Keshavarzian N, Rabiemajd S, Mosayebi G. Cytokine profile and disease severity in patients with COVID-19. Cytokine. enero de 2021;137:155323.
Ng JJ, Liang ZC, Choong AMTL. The incidence of pulmonary thromboembolism in COVID-19 patients admitted to the intensive care unit: a meta-analysis and meta-regression of observational studies. j intensive care. diciembre de 2021;9(1):20.
Xu X, Yang Y, Liu S, Zhu G, Li C-S, Wang C. Prevalence and incidence of deep venous thrombosis among patients in medical intensive care unit. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi. 2008;29:1034-7.
Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol. septiembre de 2020;17(9):543-58.
Lindner D, Fitzek A, Bräuninger H, Aleshcheva G, Edler C, Meissner K, et al. Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases. JAMA Cardiol. 1 de noviembre de 2020;5(11):1281-5.
de Jong S, van Veen TAB, van Rijen HVM, de Bakker JMT. Fibrosis and Cardiac Arrhythmias: Journal of Cardiovascular Pharmacology. junio de 2011;57(6):630-8.
Lazzerini PE, Laghi-Pasini F, Boutjdir M, Capecchi PL. Cardioimmunology of arrhythmias: the role of autoimmune and inflammatory cardiac channelopathies. Nat Rev Immunol. enero de 2019;19(1):63-4.
Meijers B, Hilbrands LB. The clinical characteristics of coronavirus-associated nephropathy. Nephrology Dialysis Transplantation. 1 de agosto de 2020;35(8):1279-81.
Braun F, Lütgehetmann M, Pfefferle S, Wong MN, Carsten A, Lindenmeyer MT, et al. SARS-CoV-2 renal tropism associates with acute kidney injury. The Lancet. agosto de 2020;396(10251):597-8.
Post A, den Deurwaarder ESG, Bakker SJL, de Haas RJ, van Meurs M, Gansevoort RT, et al. Kidney Infarction in Patients With COVID-19. American Journal of Kidney Diseases. septiembre de 2020;76(3):431-5.
Javed B, Sarwer A, Soto EB, Mashwani Z. The coronavirus (COVID‐19) pandemic’s impact on mental health. Int J Health Plann Mgmt. 2020;35(5):993-6.
Heneka MT, Golenbock D, Latz E, Morgan D, Brown R. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alz Res Therapy. diciembre de 2020;12(1):69.
Reichard RR, Kashani KB, Boire NA, Constantopoulos E, Guo Y, Lucchinetti CF. Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathol. julio de 2020;140(1):1-6.
Suwanwongse K, Shabarek N. Newly diagnosed diabetes mellitus, DKA, and COVID‐19: Causality or coincidence? A report of three cases. J Med Virol. febrero de 2021;93(2):1150-3.
Lundholm MD, Poku C, Emanuele N, Emanuele MA, Lopez N. SARS-CoV-2 (COVID-19) and the Endocrine System. Journal of the Endocrine Society. 1 de noviembre de 2020;4(11):bvaa144.
Gentile S, Strollo F, Mambro A, Ceriello A. COVID-19, ketoacidosis and new-onset diabetes: Are there possible cause and effect relationships among them? Diabetes Obes Metab. diciembre de 2020;22(12):2507-8.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 AVFT – Archivos Venezolanos de Farmacología y Terapéutica
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
